Longtime executive Tony Coles on biotech, racism, and opportunities for change
The killing of George Floyd at the hands of a white Minneapolis police officer has brutally underlined the systemic racism that informs policing, housing, education, and health care in the U.S. Biotech, like every other facet of society, is not immune to the effects of racism and inequality.
We talked to Tony Coles, a longtime biotech executive, about why Floyd’s killing sparked global action, how to parse public statements from major drug companies, and what business leaders can do to combat racism.
